(Q46788644)

25 December 2017

title

Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin (English)

1 reference

25 December 2017

1 reference

Christine L Oltman

1

1 reference

25 December 2017

Eric P Davidson

2

1 reference

25 December 2017

Lawrence J Coppey

3

1 reference

25 December 2017

Travis L Kleinschmidt

4

1 reference

25 December 2017

Donald D Lund

5

1 reference

25 December 2017

Mark A Yorek

6

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

16

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

82-89

1 reference

25 December 2017

The spectrum of neuropathy in diabetes and impaired glucose tolerance

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

H2 clearance measurement of blood flow: a review of technique and polarographic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

The Zucker fatty rat as a genetic model of obesity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Oxidative stress in a rat model of obesity-induced hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Lower force and impaired performance during high-intensity electrical stimulation in skeletal muscle of GAMT-deficient knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Therapy insight: neurological complications of prediabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Idiopathic neuropathy, prediabetes and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Small fiber neuropathy and neurovascular disturbances in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Is there a rationale for angiotensin blockade in the management of obesity hypertension?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

The renin angiotensin system as a therapeutic target to prevent diabetes and its complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Management of metabolic syndrome: statins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Statins for diabetic cardiovascular complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Statin use in the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Oxidative damage and tyrosine nitration from peroxynitrite

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Thiobarbituric acid value on fresh homogenate of rat as a parameter of lipid peroxidation in aging, CCl4 intoxication, and vitamin E deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Physiological regulation of NEFA availability: lipolysis pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Why does atherosclerosis occur where it occurs?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Lipid-lowering therapy in patients with peripheral arterial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Pharmacological treatment of patients with peripheral arterial disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Peripheral vascular disease and type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Erythrocyte Na+, K+ and Ca2+, Mg(2+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Angiotensin-converting enzyme inhibition, intracellular Na+, and Na(+)-K+ pumping in cardiac myocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

HMG CoA reductase inhibition reduces sarcolemmal Na+–K+ pump density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Protection of sensory function in diabetic rats by Neotrofin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Oxidant stress, inflammation and atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Obesity and endothelial dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

FFAs: do they play a role in vascular disease in the insulin resistance syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

7 January 2021

inferred from DOI database lookup

Statins: potent vascular anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.19

7 January 2021

inferred from DOI database lookup

Identifiers

1 reference

https://api.fatcat.wiki/v0/release/ghbik3q3tncw5km3i3v6bvqyiq

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ghbik3q3tncw5km3i3v6bvqyiq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ghbik3q3tncw5km3i3v6bvqyiq

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/ghbik3q3tncw5km3i3v6bvqyiq

30 July 2022